Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China flag China · Delayed Price · Currency is CNY
12.29
+0.27 (2.25%)
Oct 23, 2026, 3:04 PM CST

SHE:300003 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
6,0326,3446,0597,91610,55310,613
Other Revenue
138.99138.9944.264.2456.9346.74
6,1716,4836,1037,98010,60910,660
Revenue Growth
-1.37%6.22%-23.52%-24.79%-0.47%32.61%
Cost of Revenue
2,5302,4452,5562,9824,0214,166
Gross Profit
3,6414,0383,5474,9986,5886,494
Selling, General & Admin
1,7561,8782,2362,4402,7762,858
Research & Development
915.94792.38769.56879.42957.06907.94
Other Operating Expenses
181.0269.4363.2858.3733.9103.14
Operating Expenses
2,9032,7793,1193,4043,7933,882
Operating Income
738.571,259427.991,5942,7952,612
Interest Expense
-264.43-176.64-181-170.65-188.78-228.49
Interest & Investment Income
106.6120.96115.51115.3487.9957.59
Currency Exchange Gain (Loss)
-49.71-49.7126.91-25.3816.146.58
Other Non Operating Income (Expenses)
-23.38-31.3-34.13-4.22-25.77-79.03
EBT Excluding Unusual Items
507.651,122355.291,5092,6842,368
Impairment of Goodwill
---62.95-33.45--
Gain (Loss) on Sale of Investments
35.571.55-89.32-13.44-70.91-367.54
Gain (Loss) on Sale of Assets
7.814.8711.73-4.070.0219.9
Asset Writedown
-35.57-39.62-65.5-6.93-1.72-2.39
Other Unusual Items
181.67126.976.52103.55-127.71
Pretax Income
697.131,216225.761,5542,6122,146
Income Tax Expense
72.49197.0728.47262.15365.73365.73
Earnings From Continuing Operations
624.641,019197.291,2922,2461,780
Minority Interest in Earnings
33.6-5749.64-34.15-42.28-61.09
Net Income
658.24962.01246.941,2582,2041,719
Net Income to Common
658.24962.01246.941,2582,2041,719
Net Income Growth
54.40%289.57%-80.37%-42.91%28.18%-4.58%
Shares Outstanding (Basic)
1,8431,8431,8481,8621,8021,792
Shares Outstanding (Diluted)
1,8431,8431,8481,8621,8171,808
Shares Change
-0.03%-0.27%-0.74%2.48%0.50%1.75%
EPS (Basic)
0.360.520.130.681.220.96
EPS (Diluted)
0.360.520.130.681.210.95
EPS Growth
54.45%290.64%-80.23%-44.29%27.54%-6.22%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
476.15873.8675.82145.691,8852,078
Free Cash Flow Per Share
0.260.470.040.081.041.15
Dividend Per Share
0.1630.3260.2770.3310.3410.275
Dividend Growth
684.34%17.51%-16.42%-2.81%24.00%20.61%
Gross Margin
59.01%62.28%58.12%62.63%62.10%60.92%
Operating Margin
11.97%19.42%7.01%19.97%26.34%24.50%
Profit Margin
10.67%14.84%4.05%15.77%20.77%16.13%
Free Cash Flow Margin
7.72%13.48%1.24%1.83%17.77%19.49%
EBITDA
1,3831,841927.052,0403,2053,004
EBITDA Margin
22.41%28.40%15.19%25.57%30.21%28.18%
D&A For EBITDA
644.02581.89499.06446.75410.11392.37
EBIT
738.571,259427.991,5942,7952,612
EBIT Margin
11.97%19.42%7.01%19.97%26.34%24.50%
Effective Tax Rate
10.40%16.21%12.61%16.86%14.00%17.04%
Revenue as Reported
6,1716,4836,1037,98010,60910,660
Advertising Expenses
-20.1928.4984.2360.0876.04